Proteomic analysis of proteins involved in mitochondria-to-nucleus retrograde response in human cancer cells

All tumors examined to date contain mutations in mitochondrial DNA (mtDNA). In addition, depletion of mtDNA is reported in a variety of tumors. Mitochondrial dysfunction resulting from changes in mtDNA invokes mitochondria-to-nucleus retrograde response in human cells. To identify proteins involved in retrograde response and their potential role in tumorigenesis, we carried out a comparative proteomic analysis using a cell line in which the mitochondrial genome was completely depleted (?0 cells lacking all mtDNA-encoded protein subunits), a cybrid cell line in which mtDNA was restored, and the parental cell line. Our comparative proteomic approach revealed marked changes in the cellular proteome and led us to identify quantitative changes in expression of several proteins. We found that subunits of complex I and complex III, molecular chaperones, and a protein involved in cell cycle control were down-regulated and Inosine 5’-monophosphate dehydrogenase type 2 (IMPDH2) involved in nucleotides biosynthesis was up-regulated in ?0 cells. Our findings demonstrate that the expression of proteins is restored to wild type level by transfer of wild type mitochondria to ?0 cells, suggesting that these proteins play key roles in retrograde response. To determine a potential role for identified retrograde responsive proteins in tumorigenesis, we analyzed the expression of UQCRC1 gene (encoding ubiquinol cytochrome-c reductase core protein I) in breast and ovarian tumors. We found that 1) UQCRC1 was highly expressed in breast (74%) and ovarian tumors (34%) and 2) the expression positively correlated with cytochrome c-oxidase (COXII) encoded by mtDNA. Our study opens an avenue for identification of retrograde proteins as potential tumor suppressors or oncogenes involved in carcinogenesis.

[1]  J. Modica-Napolitano,et al.  Mitochondria as targets for detection and treatment of cancer , 2002, Expert Reviews in Molecular Medicine.

[2]  S. Sukumar,et al.  Tumor‐specific changes in mtDNA content in human cancer , 2005, International journal of cancer.

[3]  Keshav K. Singh,et al.  Mitochondrial impairment in p53-deficient human cancer cells. , 2003, Mutagenesis.

[4]  K Kojima,et al.  FLJ10849, a septin family gene, fuses MLL in a novel leukemia cell line CNLBC1 derived from chronic neutrophilic leukemia in transformation with t(4;11)(q21;q23) , 2004, Leukemia.

[5]  H. Ploegh,et al.  Activity-based ubiquitin-specific protease (USP) profiling of virus-infected and malignant human cells. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Keshav K. Singh,et al.  Mitochondrial DNA determines the cellular response to cancer therapeutic agents , 1999, Oncogene.

[7]  K. Gülow,et al.  BiP is feed-back regulated by control of protein translation efficiency. , 2002, Journal of cell science.

[8]  M. Kinoshita,et al.  Roles of septins in the mammalian cytokinesis machinery. , 2001, Cell structure and function.

[9]  F. Collart,et al.  Chromosomal localization and structure of the human type II IMP dehydrogenase gene (IMPDH2). , 1993, Genomics.

[10]  G. Shadel,et al.  Mitochondrial DNA maintenance in vertebrates. , 1997, Annual review of biochemistry.

[11]  N. Larsson,et al.  Revolution in mitochondrial medicine , 1999, FEBS letters.

[12]  Bjoern Linnartz,et al.  Comprehensive Scanning of Somatic Mitochondrial DNA Alterations in Acute Leukemia Developing from Myelodysplastic Syndromes , 2004, Cancer Research.

[13]  M. Kinoshita.  The septins , 2003, Genome Biology.

[14]  R. Jackson,et al.  IMP dehydrogenase, an enzyme linked with proliferation and malignancy , 1975, Nature.

[15]  N. Avadhani,et al.  Mitochondrial signaling: the retrograde response. , 2004, Molecular cell.

[16]  L. Sobin,et al.  The international histological classification of tumours. , 1981, Bulletin of the World Health Organization.

[17]  Keshav K. Singh,et al.  Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors , 2005, Cancer biology & therapy.

[18]  M. Ryan,et al.  A mitochondrial specific stress response in mammalian cells , 2002, The EMBO journal.

[19]  M. King,et al.  Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. , 1989, Science.

[20]  J. Smeitink,et al.  Cell biological consequences of mitochondrial NADH: ubiquinone oxidoreductase deficiency. , 2004, Current neurovascular research.

[21]  V. Skulachev.  Mitochondrial physiology and pathology; concepts of programmed death of organelles, cells and organisms. , 1999, Molecular aspects of medicine.

[22]  J. T. Wachsman,et al.  Mitochondrial DNA in human malignancy. , 2001, Mutation research.

[23]  G. Enns.  The contribution of mitochondria to common disorders. , 2003, Molecular genetics and metabolism.

[24]  D. Wallace.  Mitochondrial diseases in man and mouse. , 1999, Science.

[25]  L. Rasmussen,et al.  Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. , 2003, Nucleic acids research.

[26]  J. Reinstein,et al.  Modulation of the ATPase cycle of BiP by peptides and proteins. , 2003, Journal of molecular biology.

[27]  R. W. Scarff,et al.  Histological typing of breast tumors. , 1982, Tumori.

[28]  Sushant Kachhap,et al.  Nuclear genes involved in mitochondria-to-nucleus communication in breast cancer cells , 2002, Molecular Cancer.

[29]  E. Schon,et al.  Rescue of a deficiency in ATP synthesis by transfer of MTATP6, a mitochondrial DNA-encoded gene, to the nucleus , 2002, Nature Genetics.

[30]  Keshav K. Singh.  Mitochondrial Dysfunction Is a Common Phenotype in Aging and Cancer , 2004, Annals of the New York Academy of Sciences.

[31]  D. Hardie,et al.  CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. , 2004, The Journal of clinical investigation.

[32]  F. Collart,et al.  Increased inosine-5'-phosphate dehydrogenase gene expression in solid tumor tissues and tumor cell lines. , 1992, Cancer research.

[33]  K. Umezawa,et al.  Induction by the guanosine analogue oxanosine of reversion toward the normal phenotype of K-ras-transformed rat kidney cells. , 1989, Cancer research.

[34]  E. Schon,et al.  New insights into the bioenergetics of mitochondrial disorders using intracellular ATP reporters. , 2003, Molecular biology of the cell.

[35]  Resistance of Mitochondrial DNA-depleted Cells against Cell Death , 2004, Journal of Biological Chemistry.

[36]  P. Neufer,et al.  Nuclear responses to depletion of mitochondrial DNA in human cells. , 1995, The American journal of physiology.

[37]  M. Balakirev,et al.  Otubains: a new family of cysteine proteases in the ubiquitin pathway , 2003, EMBO reports.

[38]  P. Bouvet,et al.  Structure and functions of nucleolin. , 1999, Journal of cell science.

[39]  S. Dimauro.  Lessons from mitochondrial DNA mutations. , 2001, Seminars in cell & developmental biology.

[40]  A. Schapira,et al.  Mitochondrial respiratory chain disorders I: mitochondrial DNA defects , 2000, The Lancet.

[41]  Pen-Hui Yin,et al.  Mitochondrial Genome Instability and mtDNA Depletion in Human Cancers , 2005, Annals of the New York Academy of Sciences.

[42]  Erkki Ruoslahti,et al.  Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels , 2003, The Journal of cell biology.

[43]  A. Schapira.  The “new” mitochondrial disorders , 2002, Journal of neurology, neurosurgery, and psychiatry.

[44]  T. Sengupta,et al.  Identification of Nucleolin as an AU-rich Element Binding Protein Involved in bcl-2 mRNA Stabilization* , 2004, Journal of Biological Chemistry.

[45]  A. van Dorsselaer,et al.  Proteomic analysis of nuclear proteins from proliferative and differentiated human colonic intestinal epithelial cells , 2004, Proteomics.

[46]  M. Beal,et al.  Mitochondrial DNA from platelets of sporadic ALS patients restores normal respiratory functions in ρ0 cells , 2003, Experimental Neurology.

[47]  J. Taanman,et al.  The mitochondrial genome: structure, transcription, translation and replication. , 1999, Biochimica et biophysica acta.

[48]  J. Borowiec,et al.  Stress-Dependent Nucleolin Mobilization Mediated by p53-Nucleolin Complex Formation , 2002, Molecular and Cellular Biology.

[49]  Minetta C. Liu,et al.  Detection of LOH and Mitochondrial DNA Alterations in Ductal Lavage and Nipple Aspirate Fluids from High-risk Patients , 2004, Breast Cancer Research and Treatment.

[50]  M. Ünlü,et al.  Difference gel electrophoresis. A single gel method for detecting changes in protein extracts , 1997, Electrophoresis.

[51]  L. Rasmussen,et al.  Mitochondrial impairment is accompanied by impaired oxidative DNA repair in the nucleus. , 2003, Mutagenesis.

[52]  B. Kemp.  Bateman domains and adenosine derivatives form a binding contract. , 2004, The Journal of clinical investigation.

[53]  Sun Young Park,et al.  Cellular aging of mitochondrial DNA-depleted cells. , 2004, Biochemical and biophysical research communications.

[54]  B. Rowan,et al.  Src Kinase and Mitogen-Activated Protein Kinases in the Progression from Normal to Malignant Endometrium , 2004, Clinical Cancer Research.

[55]  A. Cheung,et al.  High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. , 2001, Cancer research.

[56]  M. Saraste.  Oxidative phosphorylation at the fin de siècle. , 1999, Science.

[57]  M. Mattson,et al.  Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. , 2003, Trends in molecular medicine.

[58]  J. Borowiec,et al.  Formation of a Complex between Nucleolin and Replication Protein a after Cell Stress Prevents Initiation of DNA Replication , 2000, The Journal of cell biology.

[59]  Joseph Geradts,et al.  Inter-genomic cross talk between mitochondria and the nucleus plays an important role in tumorigenesis. , 2005, Gene.

[60]  A. Parekh.  Mitochondrial regulation of intracellular Ca2+ signaling: more than just simple Ca2+ buffers. , 2003, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[61]  D. Roth,et al.  Novel roles for mammalian septins: from vesicle trafficking to oncogenesis. , 2001, Journal of cell science.

[62]  G. Bailliet,et al.  Mitochondrial DNA mutations in normal and tumor tissues from breast cancer patients. , 1995, Cytogenetics and cell genetics.

[63]  J. Hayashi,et al.  Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[64]  F. Allain,et al.  Molecular basis of sequence‐specific recognition of pre‐ribosomal RNA by nucleolin , 2000, The EMBO journal.

[65]  M. Zeviani,et al.  Complex I deficiency is associated with 3243G:C mitochondrial DNA in osteosarcoma cell cybrids. , 1996, Human molecular genetics.

[66]  C. Chi,et al.  Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer , 2005, Genes, chromosomes & cancer.